What does the "N" in NRTIs stand for?

What does the "N" in NRTIs stand for?

• A. Nucleoside
• B. Nucleotide
• C. Neuraminidase
• D. Non-nucleoside

Answer: (A)

The "N" in NRTIs stands for "Nucleoside," which is a key component of their mechanism of action. NRTIs, or nucleoside reverse transcriptase inhibitors, are antiviral drugs that mimic the natural nucleosides, which are the building blocks of DNA and RNA. By incorporating themselves into the viral DNA chain during replication, NRTIs effectively prevent further elongation of the DNA strand, leading to termination of viral replication. Understanding the role of nucleosides is crucial, particularly in the context of HIV treatment, as these agents target the reverse transcriptase enzyme essential for viral RNA to be converted into DNA. This action disrupts the lifecycle of the virus and is fundamental to the efficacy of these drugs in managing infections. Other options, such as nucleotide, refer to a slightly different class of antiviral agents known as nucleotides, which also have a similar mechanism of action but differ in their structure and functionality. Neuraminidase inhibitors target a different pathway in viral replication, especially in influenza viruses, and non-nucleoside inhibitors behave similarly to NRTIs but do not involve being incorporated into the DNA chain. Each of these terms signifies different classes of antiviral agents, but specifically, NRTIs are

The "N" in NRTIs stands for "Nucleoside," which is a key component of their mechanism of action. NRTIs, or nucleoside reverse transcriptase inhibitors, are antiviral drugs that mimic the natural nucleosides, which are the building blocks of DNA and RNA. By incorporating themselves into the viral DNA chain during replication, NRTIs effectively prevent further elongation of the DNA strand, leading to termination of viral replication.

Understanding the role of nucleosides is crucial, particularly in the context of HIV treatment, as these agents target the reverse transcriptase enzyme essential for viral RNA to be converted into DNA. This action disrupts the lifecycle of the virus and is fundamental to the efficacy of these drugs in managing infections. Other options, such as nucleotide, refer to a slightly different class of antiviral agents known as nucleotides, which also have a similar mechanism of action but differ in their structure and functionality. Neuraminidase inhibitors target a different pathway in viral replication, especially in influenza viruses, and non-nucleoside inhibitors behave similarly to NRTIs but do not involve being incorporated into the DNA chain. Each of these terms signifies different classes of antiviral agents, but specifically, NRTIs are